Abstract
Objective
The aim of this study is to evaluate utilization of intensity modulated radiation therapy (IMRT) for vulvar cancer between 2004 and 2012, and determine the survival impact of IMRT and 2D/3D radiation therapy (RT) for women treated with postoperative, preoperative, or primary radiation.
Methods
Women with vulvar carcinoma who received IMRT or 2D/3D RT were identified in the National Cancer Data Base (NCDB) between 2004 and 2012. Patient characteristics were compared between those that received IMRT and 2D/3D RT using chi-square, Fisher’s exact, and Mann-Whitney tests. Women were stratified by treatment approach, and overall survival (OS) was estimated via the Kaplan-Meier method and compared using the log-rank test. Factors associated with OS were determined using univariate and multivariate Cox proportional hazards regression models.
Results
A total of 6027 women were included (median age 67 years). Women received either 2D/3D RT (n = 4723) or IMRT (n = 1304). A total of 3.3% of women received IMRT in 2004, compared to 19.3% in 2008 and 43.0% in 2012. More women in the IMRT cohort received radiation doses >55 Gy compared to the 2D/3D RT cohort (47.5 vs. 40.3%, p < 0.001). Women received postoperative radiation (n = 3395), preoperative radiation (n = 478), or primary radiation (n = 1852). On multivariate analyses, the effect of radiation technique (IMRT vs. 2D/3D RT) on OS among women receiving post-operative, pre-operative, or primary radiation was not significant (p > 0.05).
Conclusions
IMRT utilization for vulvar cancer increased between the years 2004 and 2012. Survival was not significantly compromised with the use of IMRT compared to conventional 2D/3D RT techniques and may have allowed for dose escalation in some situations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30
Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38(2):381–389
Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP (2013) Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 130(3):545–549
Homesley HD, Bundy BN, Sedlis A, Adcock L (1986) Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68(6):733–740
Moore DH, Ali S, Koh W-J, Michael H, Barnes MN, McCourt CK et al (2012) A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 124(3):529–533
Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G (1998) Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group. Int J Radiat Oncol Biol Phys 42(1):79–85
Gilroy JS, Amdur RJ, Louis DA, Li JG, Mendenhall WM (2005) Irradiating the groin nodes without breaking a leg: a comparison of techniques for groin node irradiation. Med Dosim 29(4):258–264
Beriwal S, Coon D, Heron DE, Kelley JL, Edwards RP, Sukumvanich P et al (2008) Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol 109(2):291–295
Beriwal S, Shukla G, Shinde A, Heron DE, Kelley JL, Edwards RP et al (2013) Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys 85(5):1269–1274
Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Contract No
Chapman BV et al (2017) Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the national cancer data base. Int J Radiat Oncol Biol Phys 97(1):107–117
Gaffney DK et al (2016) Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol Biol Phys 95(4):1191–1200
Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C et al (2000) Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer 89(1):116–122
Guadagnolo BA, Liu CC, Cormier JN, Du XL (2010) Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005. Cancer 116(14):3505–3512
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was not supported by any sources of funding.
Conflict of interest
DN, JH, JF, LH, and JC have no conflicts of interest to disclose. JS is a member of the Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry, supported by GlaxoSmithKline, NovoNordisk, Astra Zeneca, and Eli Lilly.
Ethical approval
The Institutional Review Board granted exempt status for this retrospective cohort study.
Informed consent
For this type of study, formal consent is not required.
Additional information
The data used in the study are derived from a de-identified NCDB file. The American College of Surgeons and the Commission on Cancer have not verified and are not responsible for the analytic or statistical methodology employed, or the conclusions drawn from these data by the investigator.
Rights and permissions
About this article
Cite this article
Natesan, D., Hong, J.C., Foote, J. et al. Increasing utilization of intensity modulated radiation therapy in vulvar cancer: National Practice Patterns 2004–2012. J Radiat Oncol 6, 197–206 (2017). https://doi.org/10.1007/s13566-017-0312-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-017-0312-9